| http://www.w3.org/ns/prov#value | - According to the guideline, asymptomatic men with a PSA level of 3 ng/mL or less who are screened regularly with PSA tests or are anticipating having annual PSA screening for early detection of prostate cancer may benefit from a discussion of both the advantages of taking 5??-reductase inhibitors for seven years to prevent prostate cancer and the potential risks, such as the possibility of high-gr
|
